Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
| Status: | Recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Neurology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 9/29/2018 |
| Start Date: | August 28, 2018 |
| End Date: | August 2020 |
| Contact: | Neeru Sarin, MBBS |
| Email: | neeru.sarin@duke.edu |
| Phone: | 919-668-5341 |
The purpose of this study is to develop a novel noninvasive bedside optical coherence
tomography (OCT) imaging technique in newborn infants with HIE that improves our ability to
assess the range of retinal effects from HIE and to diagnose and monitor treatments of HIE.
tomography (OCT) imaging technique in newborn infants with HIE that improves our ability to
assess the range of retinal effects from HIE and to diagnose and monitor treatments of HIE.
Inclusion Criteria:
Infants are eligible if:
- Admitted to the intensive care nursery, outborn or inborn, with a clinical diagnosis
of HIE; and with the approval of the neonatologist
- A parent or legal guardian provides written informed consent
Exclusion Criteria:
Potentially eligible infants will be excluded if:
• Congenital or chromosomal anomaly that has a profound impact on brain or eye development
(e.g. anencephaly, congenital cataract or Peter's anomaly) and infants for whom there has
been a clinical decision to limit life support.
We found this trial at
2
sites
201 Presidents Circle
Salt Lake City, Utah 84108
Salt Lake City, Utah 84108
801) 581-7200
Principal Investigator: Mary Elizabeth Hartnett, MD
Phone: 801-585-6645
University of Utah Research is a major component in the life of the U benefiting...
Click here to add this to my saved trials
Durham, North Carolina
Principal Investigator: Cynthia A Toth, MD
Phone: 919-668-5341
Click here to add this to my saved trials